Other Meeting Options Related to Human Drugs
Patient group, Patient advocacy organization
Patient Engagement, Cross-center
Learn about FDA Patient Engagement
Patient group, Patient advocacy organization
Patient Engagement, Cross-center
Learn about the Patient Engagement Collaborative
Patient group, Patient advocacy organization
Patient Engagement, Cross-center
Learn about the FDA Patient Representative Program
Patient group, Patient advocacy organization, Health care professional organization
Patient Engagement, Cross-center
Submit a Meeting Request to FDA’s Public Engagement Staff
Patient group, Patient advocacy organization
Patient Engagement
Follow the procedure for requesting a Patient Listening Session Meeting
Patient group, Patient advocacy organization
Cancer/Oncology
Learn more at Project Community
Patient group, Patient advocacy organization
Patient-Focused Drug Development
Follow the procedure for conducting an Externally-Led Patient-Focused Drug Development Meeting
Industry sponsor
New drug development
Follow the procedure for Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products
Industry sponsor
Complex generic drug development
Follow the procedure for Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA
Industry sponsor
Pre-investigational new drug application
Review Frequently Asked Questions on the Pre-IND Meeting
Industry sponsor
Novel products and development programs, Pre-investigational new drug application
Follow the procedure for Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products to request an INTERACT meeting
Industry professional organization, Consortia
Investigational new drug applications, New drug development, Complex generic drug development, Human drug products, Cancer/Oncology
Register for an upcoming conference hosted by CDER Small Business and Industry Assistance
Patient Group, Patient advocacy group, Professional organization, Other non-sponsor group, Academia, Health care professional organization, Charitable foundation, Global organization, Service provider, Other government agency, Industry professional organization, Consortia, General public
Human drug products
Follow the procedure to Request a Meeting on Drugs through Professional Affairs and Stakeholder Engagement (PASE) Staff
Patient group, Patient advocacy organization, Industry sponsor, Industry professional organization, Consortia, Professional organization, Other non-sponsor group, Academia, Other government agency
Methodology or technology to advance drug development
Follow the procedure for Critical Path Innovation Meetings (CPIM)
Industry sponsor, Industry professional organization, Consortia, Industry professional organization, Other non-sponsor group, Health care professional organization, Charitable foundation, Academia, Global organization, Service provider, Other government agency
Methodology or technology to advance drug development
Follow the procedure for Drug Development Tools including Digital Health Technologies, Decentralized Clinical Trials
Patient group, Patient advocacy organization, Industry sponsor, Industry professional organization, Consortia, Professional organization, Other non-sponsor group, Academia, Charitable foundation, Health care professional organization, Global organization, Service provider, Other government agency
Speech, presentation, or participation in an external event, Human drug products
To request a CDER speaker for an external event, follow the procedure for the Speaker Request Form
Patient group, Patient advocacy organization, Industry sponsor, Industry professional organization, Consortia, Professional organization, Other non-sponsor group, Academia, Global organization, Charitable foundation, Health care professional organization, Service provider, Other government agency
Public Private Partnership, Consortium
Learn more about Engagement with Public Private Partnerships and Consortia
Patient group, Patient advocacy organization, Industry sponsor, Industry professional organization, Consortia, Professional organization, Other non-sponsor group, Academia, Charitable foundation, Health care professional organization, Global organization, Service provider, Other government agency, General public
Human drug products, Cross-center, Cancer/Oncology, Patient Engagement, New drug development, Novel products and development programs
Learn more about Advisory Committee meetings
Patient group, Patient advocacy organization, Industry sponsor, Industry professional organization, Consortia, Professional organization, Global organization, Other non-sponsor group, Academia, Charitable foundation, Health care professional organization, Service provider, Other government agency, General public
Human drug products, Cross-center, Cancer/Oncology, Patient Engagement, Methodology or technology to advance drug development, New drug development, Complex generic drug development, Pre-investigational new drug application, Novel products and development programs
Attend a public meeting involving FDA
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
